RHHVF

$299.36

▼-0.24%

wb_incandescent Backtest

Stock

Roche Holding AG

Official Company Name: Roche Holding AG

Stock Symbol: RHHVF

Stock Market: OTC Markets - Pink - OTC

Currency: United States dollar - USD

business Roche Company Profile

RHHVF Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▲+13.74%

file_download

Daily closing prices, with moving averages and volumes - United States dollar (USD)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Roche is a global healthcare company involved in prescription pharmaceuticals and diagnostics. It offers pharmaceutical products for a range of medical conditions, including oncology, neuroscience, infectious diseases, immunology, and ophthalmology. It also provides in vitro diagnostics solutions for several indications, supplies diagnostic instruments, reagents, consumables, and test kits for research, and collaborates with other companies for drug development.

business Roche Company Profile

RHHVF Stock Data

Open $296.87
High $300.00
Low $294.78
Close $299.36
Volume 13,200
Previous Close $300.09
1-Day Change -0.73
1-Year Change 36.16
Average Daily Volume 7,057
52-Week High $336.07
52-Week Low $233.27
warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.